| Members |
targetComponentId |
| Cefoperazone sodium 2g injection (pdr for recon) |
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial |
| cefoperazonnatrium 2 g, pulver till injektionsvätska, flaska |
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial |
| Cefoperazone sodium 2g/bag injection |
Cefoperazone only product in parenteral dose form |
| cefoperazonnatrium 2 g/50 ml, infusionsvätska, lösning |
Cefoperazone only product in parenteral dose form |
| natriumcefoperazon 2 g/50 ml, infusionsvätska |
Cefoperazone only product in parenteral dose form |
| Cefotaxime + cefotaxime sodium 2ns/0gm injection |
Cefotaxime (as cefotaxime sodium) 2 g powder for solution for injection vial |
| Cefotaxime 2g injection (pdr for recon) |
Cefotaxime (as cefotaxime sodium) 2 g powder for solution for injection vial |
| cefotaxim 2 g, pulver till infusionsvätska, lösning, flaska |
Cefotaxime (as cefotaxime sodium) 2 g powder for solution for injection vial |
| Cefotaxime 2ns/cefotaxime 0gm injection solution vial |
Cefotaxime (as cefotaxime sodium) 2 g powder for solution for injection vial |
| cefotaximnatrium 10 g, infusionsvätska, lösning, flaska |
Product containing precisely cefotaxime sodium 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| cefotaximnatrium 1 g/50 ml, infusionsvätska, lösning |
Cefotaxime (as cefotaxime sodium) 20 mg/mL solution for injection |
| cefotaximnatrium 1 g/50 ml, infusionsvätska |
Cefotaxime (as cefotaxime sodium) 20 mg/mL solution for injection |
| Cefotaxime sodium 2g injection |
Cefotaxime (as cefotaxime sodium) 2 g powder for solution for injection vial |
| Cefotaxime sodium 2g powder for injection solution vial |
Cefotaxime (as cefotaxime sodium) 2 g powder for solution for injection vial |
| cefotaximnatrium 2 g/50 ml, infusionsvätska, lösning |
Product containing precisely cefotaxime sodium 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| cefotaximnatrium 2 g/50 ml, infusionsvätska |
Product containing precisely cefotaxime sodium 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| dinatriumcefotetan 10 g, pulver till injektionsvätska, flaska |
Product containing precisely cefotetan (as cefotetan disodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| natriumcefoxitin 10 g, pulver till injektionsvätska, flaska |
Cefoxitin (as cefoxitin sodium) 10 g powder for solution for injection vial |
| Cefpodoxime 200mg tablet |
Cefpodoxime (as cefpodoxime proxetil) 200 mg oral tablet |
| Cefpodoxime 50mg/5mL oral suspension |
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| cefpodoximproxetil 50 mg/5 ml, suspension |
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| ceftazidim 10 g, injektionsvätska, lösning, flaska |
Ceftazidime anhydrous (as ceftazidime) 10 g powder for solution for injection vial |
| Ceftazidime 10g/vial injection |
Ceftazidime anhydrous (as ceftazidime) 10 g powder for solution for injection vial |
| Ceftazidime 1g injection |
Ceftazidime 1 g powder for solution for injection vial |
| Ceftazidime 1g powder for injection |
Ceftazidime 1 g powder for solution for injection vial |
| Ceftazidime 1g/25mL injection |
Ceftazidime 1 g powder for solution for injection vial |
| Ceftazidime 1g/vial injection |
Ceftazidime 1 g powder for solution for injection vial |
| Ceftazidime 1g/vial powder |
Ceftazidime 1 g powder for solution for injection vial |
| ceftazidim 2 g, injektionsvätska, lösning, flaska |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ceftazidime 2g injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ceftazidime 2g powder |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime 2g powder for infusion solution vial |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime 2g/vial injection |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime 2gm/vil powder |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime 500mg infusion solution vial |
Ceftazidime 500 mg powder for solution for injection vial |
| Ceftazidime 500mg injection |
Ceftazidime 500 mg powder for solution for injection vial |
| Ceftazidime 500mg/vial injection |
Ceftazidime 500 mg powder for solution for injection vial |
| ceftazidimpentahydrat 100 mg, infusionsvätska, lösning, flaska |
Ceftazidime only product in parenteral dose form |
| Ceftazidime pentahydrate 1g injection |
Ceftazidime only product in parenteral dose form |
| Ceftazidime pentahydrate 1g/vial injection |
Ceftazidime only product in parenteral dose form |
| Ceftazidime pentahydrate 2g injection |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime pentahydrate 2g powder for injection |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime pentahydrate 2g/vial injection |
Ceftazidime 2 g powder for solution for injection vial |
| ceftazidimpentahydrat 6 g, injektionsvätska, lösning, flaska |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Ceftazidime pentahydrate 6g injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Ceftazidime pentahydrate 6g/vial injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Ceftazidime sodium 1g injection |
Ceftazidime 1 g powder for solution for injection vial |
| Ceftazidime sodium 1g powder for injection |
Ceftazidime 1 g powder for solution for injection vial |
| Ceftazidime sodium 2g injection |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime sodium 2g powder for injection |
Ceftazidime 2 g powder for solution for injection vial |
| ceftazidimnatrium 2 g/50 ml, infusionsvätska, lösning, påse 50 ml |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ceftazidime sodium 2g/50 mL injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| ceftazidimnatrium 2 g/50 ml, intravenös vätska, lösning, påse 50 ml |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ceftazidime sodium 2g/50mL injection |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| natriumceftizoxim 10 g, pulver till injektionsvätska, flaska |
Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| natriumceftizoxim 1 g, pulver till injektionsvätska, flaska |
Product containing precisely ceftizoxime (as ceftizoxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| natriumceftizoxim 2 g, pulver till injektionsvätska, flaska |
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
| Ceftizoxime sodium 2g/vial injection |
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
| natriumceftizoxim 500 mg, pulver till injektionsvätska, flaska |
Ceftizoxime (as ceftizoxime sodium) 500 mg powder for solution for injection vial |
| natriumceftriaxon 10 g, pulver till injektionsvätska, flaska |
Product containing precisely ceftriaxone (as ceftriaxone sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| cefuroximnatrium 15 mg/ml, injektionsvätska, lösning, påse 50 ml |
Product containing precisely cefuroxime (as cefuroxime sodium) 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| cefuroximnatrium 30 mg/ml, injektionsvätska, lösning, påse 50 ml |
Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for injection |
| Celecoxib |
Celecoxib |
| Celluella pygmaea |
Callithrix pygmaea (organism) |
| Cellulitis of foot, except toe |
Cellulitis of foot |
| Cellulitis of head, except face |
Cellulitis of head |
| Cellulomonas cellulans |
Cellulosimicrobium cellulans (organism) |
| Cellulomonas fermentans |
Actinotalea fermentans (organism) |
| natriumcellulosafosfat 300 mg/flaska, pulver för oral suspension |
Cellulose only product in oral dose form |
| Central cervical cord injury, without bony injury, C1-4 |
Central cervical cord injury, without spinal bony injury, C1-4 (disorder) |
| Central cervical cord injury, without bony injury, C5-7 |
Central cervical cord injury, without spinal bony injury, C5-7 (disorder) |
| centralt andningsstimulerande medel |
Respiratory stimulant (substance) |
| infektion i blodomloppet relaterad till central venkateter |
Infection of bloodstream co-occurrent and due to central venous catheter in situ (disorder) |
| infektion i blodomloppet relaterad till central venkateter |
Infection of bloodstream co-occurrent and due to central venous catheter in situ (disorder) |
| Centruroides sculpturatus |
Centruroides exilicauda |
| dysfunktion i kefal del av os pubis |
Superior pubic shear (finding) |
| cefalexin 125 mg/5 ml, sirap |
Cefalexin 25 mg/mL oral solution |
| cefalexin 250 mg/5 ml, sirap |
Cefalexin anhydrous (as cefalexin) 50 mg/mL oral solution |
| Cephalexin monohydrate 250mg capsule |
Product containing precisely cefalexin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| Cephalexin monohydrate 500mg capsule |
Cefalexin 500 mg oral capsule |
| Cephalic presentation |
Vertex presentation |
| Cephalophus doria |
Cephalophus zebra (organism) |
| Cephalotrichium |
Genus Strobilidium (organism) |
| cefapirinnatrium 1 g, pulver till injektionsvätska, flaska |
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Cercospora apii |
Mycocentrospora acerina |
| Cerebellar contusion with open intracranial wound and unspecified state of consciousness |
Cerebellar contusion with open intracranial wound |
| Cerebellar contusion without open intracranial wound and with unspecified state of consciousness |
Cerebellar contusion without open intracranial wound |
| Cerebellar laceration with open intracranial wound and unspecified state of consciousness |
Cerebellar laceration with open intracranial wound |
| Cerebellar laceration without open intracranial wound and with unspecified state of consciousness |
Cerebellar laceration without open intracranial wound |
| Cerebral degeneration |
Degenerative brain disorder |
| Cerebral edema |
Cerebral edema |
| syndrom med cerebral gigantism och käkcystor |
Gorlin syndrome |
| Cerebrocardiac neurosis |
Neurocirculatory asthenia |
| cerebroretinal vaskulopati |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| årlig kontroll av stroke eller cerebrovaskulär händelse |
Cerebrovascular accident annual review |
| Certoparin sodium |
Product containing certoparin (medicinal product) |
| Ceruloplasmin |
Ferroxidase |
| Cervical approach |
Transcervical approach - uterine |
| cervixutstryk taget |
Sampling of cervix for Papanicolaou smear done (situation) |
| Cervical smear biopsy taken |
Sampling of cervix for Papanicolaou smear done (situation) |
| cervixutstryk, avböjt |
Screening for malignant neoplasm of cervix declined (situation) |